Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

Vaccine

Volumn 14, Issue 9, 1996, Pages 916-922

  Huang, Li Min ^a   Lee, Chin Yun ^a   Lin, Tzou Yien ^b   Chen, Jong Min ^b   Lee, Ping Ing ^a   Hsu, Ching Ying ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Taipei Munic Matern/Child Hlth H ^*  (Taiwan)

Author keywords

Acellular pertussis vaccine; Antibody persistence; Component pertussis vaccine; Whole cell pertussis vaccine

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNIZATION; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL;

EID: 0030174874     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00257-2     Document Type: Article

References (28)

1. 1 Lambert, H.J. Epidemiology of a small pertussis outbreak in Kent County. Michigan Public Health Rep. 1965, 80, 365-369
2. 2 Centers for Disease Control. Pertussis - United States 1982 and 1983. Morbid. Mortal. Wkly Rep. 1984, 33, 573-576
3. 3 Hinman, A.R. and Koplan, J.P. Pertussis and pertussis vaccine reanalysis of benefits, risks, and costs. J. Am. Med. Assoc. 1984, 251, 3109-3113
4. 4 Miller, D.L., Alderslade, R. and Ross, E.M. Whooping cough and whooping cough vaccine: the risks and benefits debate. Epidemiol. Rev. 1982, 4, 1-24
5. 5 Mortimer, E.A.Jr and Jones, P.K. An evaluation of pertussis vaccine. Rev. Infect. Dis. 1979, 1, 927-932
6. 6 Cody, C.L., Baraff, L.J., Cherry, J.D. et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981, 68, 650-660
7. 7 Romanus, V., Jonsell, R. and Bergquist, S.-O. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr. Infect. Dis. J. 1987, 6, 664-671
8. 8 Kanai, K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J. Med. Sci. Biol. 1980, 33, 107-143
9. 9 Sato, Y., Kimura, M. and Fukumi, H. Development of a pertussis component vaccine in Japan. Lancet 1984, 1, 122-126
10. 10 Aoyama, T., Murase, Y., Kato, T. and Iwata, T. Efficacy of an acellular pertussis vaccine in Japan. J. Pediatr. 1985, 107, 180-183
11. 11 Centers for Disease Control. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use -supplementary ACIP statement. Morbid. Mortal. Wkly Rep. 1992, 41, 1-10
12. 12 Kimura, M. and Kuno-Sakai, H. Current epidemiology of pertussis in Japan 1990, 9, 705-709
13. 13 Ginaga, A., Morokuma, K., Aihara, K. et al. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin Tokai. J. Exp. Clin. Med. 1988, 13, 59-69
14. 14 Mortimer, E.A., Plotkin, S.A. and Mortimer, E.A. Vaccines. 2nd. 1994, 91-135. WB Saunders, Philadelphia
15. 15 Blumberg, D.A., Mink, C.M., Cherry, J.D. et al. Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. J. Pediatr. 1991, 119, 194-204
16. 16 Podda, A., Carapella De Luca, E., Titone, L. et al. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. J. Pediatr. 1993, 123, 81-84
17. 17 Heininger, U., Cherry, J.D., Christenson, P.D. et al. Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine 1994, 12, 81-86
18. 18 Hori, H., Afari, E.A., Akanmori, B.D. et al. A randomized controlled trial of two acellular pertussis-diphtheria-tetanus vaccines in primary immunization in Ghana: antibody responses and adverse reactions. Ann. Trop. Paediatr. 1994, 14, 91-96
19. 19 Pichichero, M.E., Green, J.L., Francis, A.B., Marsocci, S.M., Lynd, A.M. and Litteer, T. Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children. Pediatr. Infect. Dis. J. 1994, 13, 193-196
20. 20 Kamiya, H., Nii, R., Matsuda, T., Yasuda, N., Christenson, P.D. and Cherry, J.D. Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccines in 2-and 3-month-old children in Japan. Am. J. Dis. Child. 1992, 146, 1141-1147
21. 21 Sato, Y. and Sato, H. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect. Immun. 1984, 46, 415-421
22. 22 Miller, J.J.Jr, Silverberg, R.J., Saito, T.M. et al. An agglutinative reaction for Hemophilus pertussis. J. Pediatr. 1943, 22, 644-651
23. 23 Millian, S., Cherubin, C.E., Sherwin, R. and Fuerst, H.T. A serologic survey of tetanus and diphtheria in immunity in New York City. Arch. Environ. Hlth 1967, 15, 776-781
24. 24 Quevillon, M. and Chagnon, A. Microtissue culture test for the titration of low concentrations of diphtheria antitoxin in minimal amounts of human sera. Appl. Environ. Microbiol. 1973, 25, 1-4
25. 25 Manclark, C.R., Cowell, J.L. and Germner, R. Bacterial Vaccines. 1984, 69-106. Academic Press, New York
26. 26 Robbins, J.B., Pittman, M., Trolifors, B., Lagergard, T.A., Taranger, J. and Schneerson, R. Primum non noœre: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine. Ped. Infect. Dis. J. 1993, 12, 795-807
27. 27 Dellepiane, N.I., Manghi, M.A., Eriksson, P.V., di Paola, G. and Cangelosi, A. Pertussis whole-cell vaccines: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin, and adenylate cyclase. Zbl. Bakteriol. 1992, 227, 65-73
28. 28 Edwards, K.M., Decker, M.D., Graham, B.S., Mezzatesta, J., Scott, J. and Hackell, J. Adult immunization with acellular pertussis vaccine. J. Am. Med. Assoc. 1993, 269, 53-56